Faes Farma, S.A. (FRA:FFEA)

Market Cap	1.44B +2.6%
Revenue (ttm)	711.06M +30.8%
Net Income	84.18M -20.1%
EPS	0.27 -20.4%
Shares Out	n/a
PE Ratio	17.29
Forward PE	14.75
Dividend	0.10 (2.23%)
Ex-Dividend Date	Jul 2, 2026

Volume	1
Open	4.660
Previous Close	4.635
Day's Range	4.660 - 4.660
52-Week Range	4.290 - 5.490
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securiti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1933
• Employees: 2,611
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FFEA

Financial Performance

In 2025, Faes Farma's revenue was 626.99 million, an increase of 22.93% compared to the previous year's 510.04 million. Earnings were 79.63 million, a decrease of -28.49%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error